Skip to main content

ご注意

現在、日本語に対応しているのは、Luminex LTGのセクションとLuminex LTGのサービス&サポートページのみです。

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese.

Specialists in Innovation

We innovate to meet the continuous needs of the Healthcare world.

Our innovation is rapid and constant, to meet the needs of laboratories and introduce new diagnostic solutions for the clinical world.
Today, new scientific knowledge and new therapeutic approaches are driving the world of diagnostics toward increasingly technological and innovative solutions.
The mapping of the human genome, artificial intelligence applied to medicine, the development of algorithms and new technologies all define the landscape in which we are called upon to put all our innovative potential into play, to interpret new trends, and to enter new markets.

400

people dedicated to the research and development of innovative solutions

9

research and development centers worldwide

Courtesy of over 400 researchers, mainly based in Italy and the United States, and of major investments in research and development, we respond with rapid and continuous innovation to the evolution of diagnostics and Life Sciences.
To bring cutting-edge solutions and the specialty tests to laboratories all over the world, but also the different and numerous applications in the clinic and in research.

Predictive models for future diagnostics

Interview with Fabrizio Bonelli, Corporate Vice President & Chief Technology Officer at Diasorin.

Bonelli video

From diagnostics to treatment, precision as a method

Interview with Giorgio Ghignoni, Corporate Vice President & Affairs and Innovation Lead at Diasorin.

Ghignoni video

Research and development
as our hallmark

Precision

We identify new biomarkers within our offering of diagnostic tests, to provide answers on the evolution of the disease.

Precision
Innovation – Point of Care

Point of Care

As part of decentralization, we increase proximity with patients, by simplifying diagnostics processes and delivering reliable results in less than 15 minutes, comparable to those in a laboratory.

Artificial intelligence

We evaluate the severity and prognosis of the disease through the application of algorithmic diagnostics and artificial intelligence to our tests.

Innovation – Artificial intelligence